Novel ingredient development
What is Novel ingredient development?
A characterised candidate ingredient with development and evidence gaps documented.
Why do you need this service?
Use novel ingredient development to establish a candidate material, a feasible production route and a characterization package before formulation trials. Biological activity, material identity, batch consistency and safety evidence are separate development questions.
Who provides Novel ingredient development services?
Companies linked to Novel ingredient development or a more specific service
Creative BioMart Cosmetic Ingredients
Creative BioMart Cosmetic Ingredients supplies cosmetic actives, raw materials and functional ingredients, alongside testing and development services.
Gravitas Pharma Pvt Ltd
Indian specialty fine-chemical manufacturer supplying resorcinol, pyridine, phenol and other intermediates for cosmetics and hair dyes.
Ephyla
French biotech laboratory developing naturally derived cosmetic actives through responsible sourcing, biomimetic research and formulation support.
Elkay Chemicals
Indian specialty silicone manufacturer supplying oils, emulsions, surfactants and functional ingredients for personal-care formulations.
Gaia Tech AG
Swiss ingredient developer converting agrifood side streams into natural cosmetic actives, exfoliants and custom ingredient concepts.Novel ingredient development
Developing a new cosmetic ingredient involves more than detecting biological activity. Labs must establish its identity, production consistency, relevant impurities, and suitability for the proposed use. Biotechnology methods can support this work alongside chemical synthesis and botanical extraction.
Production and characterization
Depending on the material, development may involve recombinant protein production, microbial fermentation, plant cell culture, or enzymatic modification. Plant-cell-derived extracts should not be confused with living stem cells acting in human skin.
- Characterization of molecular structure using spectroscopy and chromatography
- Measurement of purity and process-related impurities
- Stability testing under relevant storage and formulation conditions
- Exploratory assessment of usable concentrations
Safety and regulatory preparation
Safety work is selected for the ingredient, exposure, and target market. It may include cytotoxicity, irritation and sensitization assessment, microbiological quality, trace contaminants, and photostability where relevant. Applicable standardized methods should be identified rather than assumed to cover every endpoint.
Analytical reports and ingredient naming documentation, including INCI information where applicable, support subsequent review. Neither an INCI name nor early laboratory activity establishes regulatory approval or clinical efficacy. The development package should make remaining evidence gaps clear before formulation progresses.
Applications of novel ingredient development
Developing a characterized candidate
A peptide, fermented material or plant-cell-derived extract needs an identity and composition appropriate to its complexity. Spectroscopy and chromatography can support characterization, while impurity and batch comparisons help define a reproducible material. Plant-cell-derived extracts should not be described as living stem cells acting in skin.
Preparing formulation and safety work
Development can compare production processes and examine storage or formulation compatibility. Concentration selection should account for activity, solubility and safety rather than a standard efficacy target. The resulting package identifies what is established and which studies remain necessary. It does not confer approval, clinical backing, patent ownership or a predictable consumer preference advantage.
Compare cosmetic ingredient production routes, biotechnology approaches and novel ingredient development, with feasibility and evidence gaps defined. Explore another Ingredient Production Processes page on cosmetic-labs.com.